Navigation Links
Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance
Date:5/14/2008

manufacturing facility have been reclassified as "assets held for sale".

This reclassification shifts $10.3 million of assets on the balance

sheet out of Property and Equipment and into Current Assets. As it

relates to the Statement of Operations depreciation is not charged

against assets held for sale, and as a consequence there will be a

significant reduction in the depreciation charge going forward.

* VaxGen's net loss of $7.5 million for the first quarter of 2008 reflects

$2.3 million of expenses associated with the terminated merger and also

reflects a non-cash charge of $1.6 million related to the increase in

value of the derivative liability associated with the Company's

convertible notes. The main reason for the increase in the derivative

liability is management's assessment that there is an increased

probability of a change of control event, as defined in the indenture

related to the notes.

* VaxGen's net cash used in operating activities of $4.9 million for the

first quarter of 2008 reflects approximately $1.8 million of cash

expended on costs related to the proposed Raven merger during the

quarter.

About VaxGen

VaxGen is a biopharmaceutical company based in South San Francisco, California. The company owns a state-of-the-art biopharmaceutical manufacturing facility with a 1,000-liter bioreactor that can be used to make cell culture or microbial biologic products. For more information, please visit the company's web site at http://www.vaxgen.com.

Note: This press release contains "forward-looking statements" within the meaning of the federal securities laws, including statements regarding the VaxGen's anticipated cash expenditures and its potential sale of assets and assignment of lease. These statements are subject to risks and uncertainties tha
'/>"/>

SOURCE VaxGen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc.
2. VaxGen and Raven Terminate Merger Agreement
3. VaxGen Issues Rebuttal to MedCap Letter
4. VaxGen Common Stock Now Quoted on OTC Bulletin Board
5. VaxGen Reports Financial Update
6. VaxGen to Present at the 10th Annual BIO CEO and Investor Conference
7. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
8. VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal
9. VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board
10. VaxGen Addresses MPM Claims in Letter to Stockholders
11. VaxGen Files Last Outstanding Periodic Report With SEC

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...stCall/--Sigma-AldrichCorporation(Nasdaq: SIAL )wi...cember1stat1:45PMGMTinLondon,7:45AMUS/CST.Interest...rnetavailableat http://inve s tor.sig m a a ...ssthisfile. ,, AboutSigma-Aldrich: Sigma-Ald...Itschemicalandbiochemicalproductsandkitsareusedins...
(Date:11/24/2009)...a/--ShanghaiBiolaxyannouncedthe,ChineseStateFood&a...ationalnewdrugapplication(IND)foritsoralinsulinpro...tdiabetes.ThisIND,approvalallowsBiolaxytoinitiatei...rdercharacteristicofhighbloodglucoseandpoor,metabo...micro-and,macro-vasculardiseases,lossofvision,kidn...
(Date:11/24/2009)...irstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),thegl...cedthatithassubmittedaMAAtotheEuropeanMedicinesAge...menttherapyindevelopment,forthetreatmentofType1Gau...velaglucerasealfathathasbeensubmitted,withprevious...edonaglobalsupplyshortageofthecurrentlyapprovedand...
(Date:11/24/2009)...tracts Service (CAS), the global expert on chemica...is now the world,s leading producer of patent inve...an,s patent office, the World Intellectual Propert...t and Trademark Office (USPTO) for more than a dec...nd exceeded Japan for the first time on a monthly ...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
... - Completed Series B Total Stands at EUR21.3 m ... focused on novel therapeutic,and preventative app...oday,announced that Roche Venture Fund and Enterpr...llion to the Series B financing announced in Febru... million. The new investors,join Novartis Venture ...
...lable in French . , An NSERC-funded lab at the U...a lithium battery that can store and deliver more ... ion batteries. , The research team of professor... postdoctoral fellow Kyu Tae Lee are one of the fi...nce for a lithium-sulphur battery. The finding is ...
...8 Charleston Laboratories, Inc., an emerging spec... opioid-induced nausea and vomiting (OINV) in opio...lly completed the Exploratory Bioequivalence Study... "These are promising data on our immediate-relea...ief Operating Officer at Charleston Laboratories, ...
Other Biology Technology:Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing 2Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing 3Canadian research team reports major breakthrough in lithium battery technology 2Charleston Laboratories, Inc. Completes Exploratory Bioequivalence Study of CL-108 2
(Date:11/23/2009)..., D.C. The community-associated strain of the dea...istant to most common antibioticsposes a far great...ng its way into hospitals, according to a study in...es . , The new threat is easily picked up in fi...d has increased the overall burden of MRSA within ...
(Date:11/23/2009)...lif. -- More than 160 participants gathered this w... FUTURES INITIATIVE conference. This year,s topic,... engineers, and medical researchers to explore the...nding the emerging field of synthetic biology. , ... at Princeton University and this year,s conferenc...
(Date:11/23/2009)... Calif. - By producing some of the highest resolut...es, scientists have a deeper understanding how bio...earch may lead to a new treatment for kidney stone...ars in the Nov. 23 online edition of the journal ...explores how peptides interact with mineral surfac...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3New Initiative to Improve Mental Health Among Chicago Latinos 52989 1New Initiative to Improve Mental Health Among Chicago Latinos 52989 2New Initiative to Improve Mental Health Among Chicago Latinos 52989 3New Initiative to Improve Mental Health Among Chicago Latinos 52989 4Courage Center Welcomes Susan Oswald as Major Gifts Director 52985 1Courage Center Welcomes Susan Oswald as Major Gifts Director 52985 2Study Shows Cancer Vaccines Led to Long Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of 4790 1Study Shows Cancer Vaccines Led to Long Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of 4790 2Study Shows Cancer Vaccines Led to Long Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of 4790 3
...ed the term "slobber knocker," is there a limit to... handle before the player suffers a concussion" , ...the University of North Carolina at Chapel Hill. H...Carolina football players over the 2004 to 2006 se...l theories about these mild traumatic brain injuri...
...ot of botanical diversity, there are more than 20,...ral thousand of them are used by traditional heale...of problems from the common cold to serious diseas...tments are will be the focus of The International ...), a collaborative research effort between the Uni...
...he United States Department of Agriculture (USDA) ...techniques" used in the production of packaged pro...ue of HortScience, simulated washing techniques to...ality and safety of pre-cut lettuce. , Yaguang Lu...tates Department of Agriculture,s (USDA) Produce Q...
Other Biology News:High-tech helmets reveal new information about the impact of hard hits to the head 2High-tech helmets reveal new information about the impact of hard hits to the head 3High-tech helmets reveal new information about the impact of hard hits to the head 4Study of African traditional medicine will begin world-first clinical trial 2Study of African traditional medicine will begin world-first clinical trial 3Fresh-cut produce washing practices can minimize food-borne illness risks 2
... StabilCoat Plus Microsphere/Microarray Stabilizer...ovine protein and other non-toxic chemicals in a P.... This product contains a combination of 0.02% me... preservative. StabilCoat Plus Stabilizer provide...
... The Corning CellBIND surface is produced by a pat...ilic surface giving more consistent, even cell att...D enhances cell attachment and growth uunder diffi...free medium. • CellBIND may provide a more ec...
Mouse Anti-PSD-95, PDZ Domain Monoclonal Antibody, Unconjugated, Clone K28/86.2 from Upstate
... Powerful data acquisition, analysis and experimen...rker data with on-line and off-line analysis. powe...in script language allowing the user to customize ...ns range from basic data logging to complex setups...
Biology Products: